Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO) (Dec, 10.1007/s13555-023-01086-9, 2023)
Por:
Pinter, A, Costanzo, A, Khattri, S, Smith, SD, Carrascosa, JM, Tada, Y, Riedl, E, Reich, A, Brnabic, A, Haustrup, N, Lampropoulou, A, Lipkovich, I, Kadziola, Z, Paul, C and Schuster, C
Publicada:
30 may 2024
Ahead of Print:
1 may 2024
Resumen:
Filiaciones:
Pinter, A:
Univ Hosp Frankfurt, Frankfurt, Germany
Costanzo, A:
Humanitas Res Hosp, Div Dermatol, Milan, Italy
Dermatol IRCCS Humanitas Res Hosp, Milan, Italy
Khattri, S:
Icahn Sch Med Mt Sinai, New York, NY USA
Smith, SD:
Australian Natl Univ, ANU Coll Hlth & Med, ANU Med Sch, Canberra, Australia
:
Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Dermatol, IGTP, Carretera Canyet S-N, Badalona 08916, Barcelona, Spain
Tada, Y:
Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan
Riedl, E:
Med Univ Vienna, Dept Dermatol, Vienna, Austria
Reich, A:
Rzeszow Univ, Med Coll, Inst Med Sci, Dept Dermatol, Rzeszow, Poland
Brnabic, A:
Eli Lilly & Co, Indianapolis, IN USA
Haustrup, N:
Eli Lilly & Co, Indianapolis, IN USA
Lampropoulou, A:
Eli Lilly & Co, Indianapolis, IN USA
Lipkovich, I:
Eli Lilly & Co, Indianapolis, IN USA
Kadziola, Z:
Eli Lilly & Co, Indianapolis, IN USA
Paul, C:
Univ Paul Sabatier Toulouse III, Toulouse, France
Schuster, C:
Med Univ Vienna, Dept Dermatol, Vienna, Austria
Eli Lilly & Co, Indianapolis, IN USA
Green Submitted, gold
|